Timing matters: new study looks at speed of blood thinner in severe lung clots

NCT ID NCT06912009

Recruiting now Knowledge-focused Sponsor: University Hospital, Strasbourg, France Source: ClinicalTrials.gov ↗

First seen Jan 04, 2026 · Last updated May 24, 2026 · Updated 20 times

Summary

This study looks at how fast patients in the intensive care unit with a serious lung clot (pulmonary embolism) receive effective blood-thinning medication. Researchers will review data from 100 adults treated between 2014 and 2023 to see how quickly their blood reached a therapeutic level and whether that timing affects survival, clot recurrence, or bleeding. The goal is to improve treatment practices for these critically ill patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Service de Réanimation Médicale - CHU de Strasbourg - France
RECRUITING

Strasbourg, 67091, France

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

PULMONARY EMBOLISM